Practical Interpretation of Increasingly Differing Payer Requirements & Efficiently Reflecting Expectations in Clinical Strategies, Overcoming Challenges in Ensuring Maximum Reimbursement for Established & Novel Tests with the Ongoing Impact of PAMA & Fluctuating Diagnostic Rates, in addition to Grey Areas in Prior Authorization Processes
In the increasingly competitive diagnostic market, coverage and reimbursement professionals seek practical insight into successful strategies to develop test-specific frameworks and meet the growing need for clinical utility and product performance evidence. In particular, tactics to clearly define end-points in diagnostic clinical trial design, as well as methods to advantageously position real-world evidence to maximize the product value demonstration to payers are currently on the industry’s radar. Proactive solutions are needed as reimbursement leaders strive to maximize profitability within the context of decreasing payment rates due to PAMA as well as increasing requirements for prior authorization. Additionally, clarity is needed regarding PLA code recognition by payers and overall effectiveness, as well as important private payer and government policy updates to swiftly integrate into reimbursement strategies.
The 15th-16th editions of the Q1 Productions Diagnostic Coverage & Reimbursement Conference will equip attendees with targeted insight into the most pressing challenges in obtaining satisfactory payments, while also providing a forward-focused look at rising trends within the industry and resulting effects on reimbursement efforts. Through sharing of perspectives on diagnostics’ place within value-based frameworks and potential for new revenue streams by partnering with pharmaceutical companies, the conference presents an unequaled opportunity for delegates to optimize strategies to drive effective payment. Featuring diverse viewpoints including small and large manufacturers, laboratories, and public and private payers, attendees will engage in peer-to-peer knowledge sharing while also benefiting from direct insight into payer perspectives on coverage and reimbursement.